Basic Research Study to Examine the Relation Between Muscle Insulin Resistance and Lipid Production in the Liver.
- Conditions
- Insulin Resistance
- Registration Number
- NCT02196051
- Lead Sponsor
- Yale University
- Brief Summary
The purpose of this study was to examine the pathophysiology of insulin resistance and the relation to the metabolic syndrome in humans.
- Detailed Description
In this study insulin resistant (IR), young offspring of parents with type 2 diabetes (18-46 years) and healthy, lean elderly individuals (65-90 years) underwent 1H/13C MRS measurements of liver and muscle lipid and glycogen content before and after a high carbohydrate meal challenge. Hepatic de novo lipogenesis was determined as the incorporation of deuterium, from deuterium labeled water (2H2O), into plasma triglycerides 5. These metabolic studies were performed in 2 sets: Study Part 1: Resting, Study Part 2: After 1 bout of 45 minutes exercise.
The study has been completed and published as two papers: August 16, 2011 and July 24, 2012.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 41
- Body Mass Index < 29 kg/m2
- No regular exercise routine
- Non-smokers
- Absence of systemic and organ disease.
- Hematocrit < 35 vol%
- History of claustrophobia
- Ferromagnetic implants
- Regular exercise regimen
- Not weight stable
- Any significant hematological, neurological, musculoskeletal or endocrine disease (including diabetes mellitus)
- Any significant cardiovascular condition, including confirmed CAD and prior cardiovascular events
- Taking coumadin as anticoagulant therapy.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method change in de novo lipogenesis Baseline At the baseline assessment, de novo lipogenesis was assessed after a high carbohydrate meal and a drink of heavy water. Muscle glycogen and lipid contents were measured pre- and post meal using 1H/13C MRS and de novo lipogenesis was assessed from the heavy water incorporation into blood lipid in samples collected overnight.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
YCCI/YNNH Hospital Research Unit
πΊπΈNew Haven, Connecticut, United States
YCCI/YNNH Hospital Research UnitπΊπΈNew Haven, Connecticut, United States